From pilots to production: AI across R&D, safety, regulatory, and clinical

Speaker(s): Sudhir Saxena, Deiva Ramachandran, & Stuart Pyle

Moderator: Surani Fernando

Life sciences organizations are moving quickly to explore generative and agentic AI, but many are still working through how to move from promising pilots to production-ready solutions that can scale across regulated workflows. As AI becomes embedded in areas such as pharmacovigilance, regulatory operations, clinical development, medical affairs, precision medicine and commercial processes, organizations need more than experimentation — they need trusted AI strategies that balance speed, quality, governance and human oversight.

In this webinar, experts from IBM and GNQ Insilico will discuss:

• How Agentic AI and AI-first strategies have accelerated time-to-value in regulatory submission processes related to IND, NDA and BLA applications, helping bring products to market faster.
• What it takes to operationalize AI across complex life sciences environments, and how biological reasoning models and quantum computing are changing what AI can actually explain — not just predict — across the molecule-to-patient journey.